While sleep supplements can be beneficial, the lack of regulation means consumers are not assured of a safe and effective product.

In the United States, digestive diseases remain a significant cause of mortality, according to an analysis of multiple national databases.

In a recent clinical guideline, recommendations are presented for the diagnosis and management of eosinophilic esophagitis.

For young individuals with cancer, residence in redlined neighborhoods is associated with lower survival at five and 10 years.

A recent study finds that physiological metrics from wearable devices can help identify inflammatory bowel disease flares.

The majority of patients with postacute sequelae of COVID-19/post-COVID-19 syndrome do not recover in the second year of their illness.

Sociodemographic, health care, and clinical factors are associated with receipt of semaglutide in those with obesity but without diabetes.

For patients diagnosed with cancer, high muscle strength and cardiorespiratory fitness associated with reduced risk for all-cause mortality.

The FDA has approved 2 additional vial sizes of Niktimvo™ (axatilimab-csfr), 9mg/0.18mL and 22mg/0.44mL, in addition to the 50mg/mL size.

Private equity acquisition of US hospitals was associated with a significant worsening of patient-reported care experiences.

Patients with cryptogenic cirrhosis and definite celiac disease experienced significant clinical benefits when following a gluten-free diet.